Intellia Therapeutics (NTLA) Cash from Operations (2015 - 2026)
Intellia Therapeutics (NTLA) reported Cash from Operations of 117346000.0 for Q1 2026, up 21.21% year-over-year from 96814317.89 in Q1 2025, and down 69.37% on a QoQ basis from 69285000.0 in Q4 2025.
Intellia Therapeutics (NTLA) has 12 years of Cash from Operations data on file, last reported at 117346000.0 in Q1 2026.
- Quarterly Cash from Operations rose 21.21% year-over-year to 117346000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 363152000.0 (up 3.71% YoY) and the FY2025 annual result came in at 394736000.0, down 13.14% from the prior year.
- Cash from Operations eased to 117346000.0 in Q1 2026 per NTLA's latest filing, from 69285000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 58186000.0 in Q2 2024 and bottomed at 148930000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 89869000.0 (2022), against an average of 93431470.59.
- The widest annual swing landed in 2024, when Cash from Operations jumped 35.58%; it then tumbled 71.21% in 2025.
- Tracing NTLA's Cash from Operations over 5 years: stood at 89869000.0 in 2022, then retreated by 3.54% to 93054000.0 in 2023, then rose by 8.45% to 85195000.0 in 2024, then advanced by 18.67% to 69285000.0 in 2025, then slumped by 69.37% to 117346000.0 in 2026.
- Per Business Quant, the three latest NTLA Cash from Operations figures stand at 117346000.0 (Q1 2026), 69285000.0 (Q4 2025), and 76899000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | -117.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.35 Mn |
| Mar 31, 2026 | -117.35 Mn |
| Dec 31, 2025 | -69.29 Mn |
| Dec 31, 2025 | -69.29 Mn |
| Sep 30, 2025 | -76.90 Mn |
| Sep 30, 2025 | -76.90 Mn |
| Jun 30, 2025 | -99.62 Mn |
| Jun 30, 2025 | -99.62 Mn |
| Mar 31, 2025 | -148.93 Mn |
| Mar 31, 2025 | -148.93 Mn |
| Dec 31, 2024 | -85.20 Mn |
| Dec 31, 2024 | -85.20 Mn |
| Sep 30, 2024 | -84.84 Mn |
| Sep 30, 2024 | -84.84 Mn |
| Jun 30, 2024 | -58.19 Mn |
| Jun 30, 2024 | -58.19 Mn |
| Mar 31, 2024 | -120.66 Mn |
| Mar 31, 2024 | -120.66 Mn |
| Dec 31, 2023 | -93.05 Mn |
| Dec 31, 2023 | -93.05 Mn |
| Sep 30, 2023 | -101.38 Mn |
| Sep 30, 2023 | -101.38 Mn |
| Jun 30, 2023 | -90.32 Mn |
| Jun 30, 2023 | -90.32 Mn |
| Mar 31, 2023 | -109.33 Mn |
| Mar 31, 2023 | -109.33 Mn |
| Dec 31, 2022 | -89.87 Mn |
| Dec 31, 2022 | -89.87 Mn |
| Sep 30, 2022 | -78.53 Mn |
| Sep 30, 2022 | -78.53 Mn |
| Jun 30, 2022 | -85.09 Mn |
| Jun 30, 2022 | -85.09 Mn |
| Mar 31, 2022 | -79.80 Mn |
| Mar 31, 2022 | -79.80 Mn |
| Dec 31, 2021 | -54.65 Mn |
| Dec 31, 2021 | -54.65 Mn |
| Sep 30, 2021 | -65.02 Mn |
| Sep 30, 2021 | -65.02 Mn |
| Jun 30, 2021 | -52.98 Mn |
| Jun 30, 2021 | -52.98 Mn |
| Mar 31, 2021 | -52.38 Mn |
| Mar 31, 2021 | -52.38 Mn |
| Dec 31, 2020 | -40.23 Mn |
| Dec 31, 2020 | -40.23 Mn |
| Sep 30, 2020 | -28.56 Mn |
| Sep 30, 2020 | -28.56 Mn |
| Jun 30, 2020 | 57.42 Mn |
| Jun 30, 2020 | 57.42 Mn |
| Mar 31, 2020 | -38.55 Mn |
| Mar 31, 2020 | -38.55 Mn |
| Dec 31, 2019 | -28.66 Mn |
| Dec 31, 2019 | -28.66 Mn |
| Sep 30, 2019 | -25.45 Mn |
| Sep 30, 2019 | -25.45 Mn |
| Jun 30, 2019 | -27.68 Mn |
| Jun 30, 2019 | -27.68 Mn |
| Mar 31, 2019 | -21.45 Mn |
| Mar 31, 2019 | -21.45 Mn |
| Dec 31, 2018 | -8.54 Mn |
| Dec 31, 2018 | -8.54 Mn |
| Sep 30, 2018 | -12.45 Mn |
| Sep 30, 2018 | -12.45 Mn |
| Jun 30, 2018 | -22.50 Mn |
| Jun 30, 2018 | -22.50 Mn |
| Mar 31, 2018 | -17.77 Mn |
| Mar 31, 2018 | -17.77 Mn |
| Dec 31, 2017 | -21.31 Mn |
| Dec 31, 2017 | -21.31 Mn |
| Sep 30, 2017 | -16.89 Mn |
| Sep 30, 2017 | -16.89 Mn |
| Jun 30, 2017 | -15.68 Mn |
| Jun 30, 2017 | -15.68 Mn |
| Mar 31, 2017 | -11.40 Mn |
| Mar 31, 2017 | -11.40 Mn |
| Dec 31, 2016 | -14.41 Mn |
| Dec 31, 2016 | -14.41 Mn |
| Sep 30, 2016 | -7.61 Mn |
| Sep 30, 2016 | -7.61 Mn |
| Jun 30, 2016 | 67.55 Mn |
| Jun 30, 2016 | 67.55 Mn |
| Mar 31, 2016 | -9.42 Mn |
| Mar 31, 2016 | -9.42 Mn |
| Dec 31, 2015 | -5.49 Mn |
| Dec 31, 2015 | -5.49 Mn |
| Sep 30, 2015 | -3.27 Mn |
| Sep 30, 2015 | -3.27 Mn |
| Jun 30, 2015 | 2.17 Mn |
| Jun 30, 2015 | 2.17 Mn |
| Mar 31, 2015 | 4.82 Mn |
| Mar 31, 2015 | 4.82 Mn |